175 related articles for article (PubMed ID: 3331321)
41. Nifedipine: a new life with GITS?
Lancet; 1992 Dec 19-26; 340(8834-8835):1507-8. PubMed ID: 1361601
[No Abstract] [Full Text] [Related]
42. Comparative dosing and efficacy of continuous-release nifedipine versus standard nifedipine for angina pectoris: clinical response, exercise performance, and plasma nifedipine levels.
Vetrovec GW; Parker VE; Alpert DA
Am Heart J; 1988 Apr; 115(4):793-8. PubMed ID: 3354408
[TBL] [Abstract][Full Text] [Related]
43. [Transdermal therapy of arterial hypertension: a new approach in the management of hypertensive patients].
Ambrosioni E
Ann Ital Med Int; 1994 Oct; 9 Suppl():54S-57S. PubMed ID: 7857759
[TBL] [Abstract][Full Text] [Related]
44. Nifedipine plasma concentration in patients treated for angina pectoris.
Stern Z; Zylber-Katz E; Levy M
Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):198-203. PubMed ID: 6715089
[TBL] [Abstract][Full Text] [Related]
45. Uric acid and other renal function parameters in patients with stable angina pectoris participating in the ACTION trial: impact of nifedipine GITS (gastro-intestinal therapeutic system) and relation to outcome.
Ruilope LM; Kirwan BA; de Brouwer S; Danchin N; Fox KA; Wagener G; Segura J; Poole-Wilson PA; Lubsen J;
J Hypertens; 2007 Aug; 25(8):1711-8. PubMed ID: 17620970
[TBL] [Abstract][Full Text] [Related]
46. Patient compliance and therapeutic coverage: amlodipine versus nifedipine SR in the treatment of hypertension and angina: interim results. Steering Committee and Cardiologists and General Practitioners involved in the Belgium Multicentre Study on Patient Compliance.
Detry JM
Clin Cardiol; 1994 Sep; 17(9 Suppl 3):III12-6. PubMed ID: 9156955
[TBL] [Abstract][Full Text] [Related]
47. Differential effects of once-daily antihypertensive drugs on blood pressure, left ventricular mass and sympathetic activity: Nifedipine-GITS versus felodipine-ER versus enalapril.
Leenen FH; Myers MG; Joyner CD; Toal CB
Can J Cardiol; 2002 Dec; 18(12):1285-93. PubMed ID: 12518180
[TBL] [Abstract][Full Text] [Related]
48. [Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension].
Witkowska M; Tracz W; Kubler G; Negrusz-Kawecka M; Hlawaty M; Olszowska M; Salamon P
Przegl Lek; 1997; 54(5):324-8. PubMed ID: 9380807
[TBL] [Abstract][Full Text] [Related]
49. The combination of slow-release nifedipine and atenolol for stable angina.
Waller DG; Challenor VF
Cardiovasc Drugs Ther; 1990 Aug; 4 Suppl 5():899-904. PubMed ID: 2076397
[TBL] [Abstract][Full Text] [Related]
50. ACTION with nifedipine GITS (Adalat XL) provides evidence for safety and improved outcome in angina patients.
Cardiovasc J S Afr; 2004; 15(5):249-51. PubMed ID: 15483737
[No Abstract] [Full Text] [Related]
51. Added benefits of nifedipine (Adalat GITS) beyond lowering blood pressure.
Cardiovasc J S Afr; 2004; 15(4):198-9. PubMed ID: 15322581
[No Abstract] [Full Text] [Related]
52. Clinical pharmacokinetics of nifedipine gastrointestinal therapeutic system. A controlled-release formulation of nifedipine.
Chung M; Reitberg DP; Gaffney M; Singleton W
Am J Med; 1987 Dec; 83(6B):10-4. PubMed ID: 3503594
[TBL] [Abstract][Full Text] [Related]
53. Clinical use of nifedipine GITS in the treatment of hypertension: an overview.
Simon A; Levenson J
Expert Opin Pharmacother; 2003 Jan; 4(1):95-106. PubMed ID: 12517246
[TBL] [Abstract][Full Text] [Related]
54. Efficacy of clonidine as transdermal therapeutic system: the international clinical trial experience.
Lowenthal DT; Saris S; Paran E; Cristal N; Sharif K; Bies C; Fagan T
Am Heart J; 1986 Oct; 112(4):893-900. PubMed ID: 3532747
[TBL] [Abstract][Full Text] [Related]
55. Patient compliance and therapeutic coverage: amlodipine versus nifedipine (slow-release) in the treatment of angina pectoris. Belgian Collaborative Group.
Detry JM; Block P; De Backer G; Degaute JP; Six R
J Int Med Res; 1994; 22(5):278-86. PubMed ID: 7867873
[TBL] [Abstract][Full Text] [Related]
56. Novel drug-delivery systems for hypertension.
Prisant LM; Bottini B; DiPiro JT; Carr AA
Am J Med; 1992 Aug; 93(2A):45S-55S. PubMed ID: 1519636
[TBL] [Abstract][Full Text] [Related]
57. Pharmacokinetics of nifedipine derived from a new retard tablet formulation.
Avgerinos A; Gorrod JW
Eur J Drug Metab Pharmacokinet; 1990; 15(4):273-8. PubMed ID: 2088764
[TBL] [Abstract][Full Text] [Related]
58. Nifedipine gastrointestinal therapeutic system.
Swanson DR; Barclay BL; Wong PS; Theeuwes F
Am J Med; 1987 Dec; 83(6B):3-9. PubMed ID: 3503595
[TBL] [Abstract][Full Text] [Related]
59. Issues in contemporary drug delivery. Part VI: Advanced cardiac drug formulations.
Hilleman DE; Banakar UV
J Pharm Technol; 1992; 8(5):203-11. PubMed ID: 10121014
[TBL] [Abstract][Full Text] [Related]
60. [Open study to evaluate the efficacy and tolerance of prolonged-action nifedipine in the treatment of mild to moderate essential arterial hypertension].
Med Clin (Barc); 1988 Oct; 91(13):493-5. PubMed ID: 3226200
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
